These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12554363)

  • 1. Stability of a transdermal salmon calcitonin formulation.
    Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
    Drug Deliv; 2003; 10(1):41-5. PubMed ID: 12554363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal iontophoretic delivery of salmon calcitonin.
    Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
    Int J Pharm; 2000 Apr; 200(1):107-13. PubMed ID: 10845691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones.
    Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
    J Control Release; 2000 May; 66(2-3):127-33. PubMed ID: 10742574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide.
    Manosroi J; Lohcharoenkal W; Götz F; Werner RG; Manosroi W; Manosroi A
    Drug Dev Ind Pharm; 2013 Apr; 39(4):520-5. PubMed ID: 22564052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis.
    Santi P; Colombo P; Bettini R; Catellani PL; Minutello A; Volpato NM
    Pharm Res; 1997 Jan; 14(1):63-6. PubMed ID: 9034222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
    Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration.
    Santi P; Volpato NM; Bettini R; Catellani PL; Massimo G; Colombo P
    Farmaco; 1997; 52(6-7):445-8. PubMed ID: 9372596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive and iontophoretic controlled delivery of salmon calcitonin through artificial membranes.
    Stamatialis DF; Rolevink HH; Koops GH
    Curr Drug Deliv; 2004 Apr; 1(2):137-43. PubMed ID: 16305379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats.
    Morimoto K; Iwakura Y; Nakatani E; Miyazaki M; Tojima H
    J Pharm Pharmacol; 1992 Mar; 44(3):216-8. PubMed ID: 1354726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo iontophoretic delivery of salmon calcitonin across microporated skin.
    Vemulapalli V; Bai Y; Kalluri H; Herwadkar A; Kim H; Davis SP; Friden PM; Banga AK
    J Pharm Sci; 2012 Aug; 101(8):2861-9. PubMed ID: 22644951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of calcitonin salmon in nasal spray at elevated temperatures.
    Cook TJ; Shenoy SS
    Am J Health Syst Pharm; 2002 Apr; 59(8):713-5. PubMed ID: 11977855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative.
    Costantino HR; Culley H; Chen L; Morris D; Houston M; Roth S; Phoenix MJ; Foerder C; Philo JS; Arakawa T; Eidenschink L; Andersen NH; Brandt G; Quay SC
    J Pharm Sci; 2009 Oct; 98(10):3691-706. PubMed ID: 19226627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats.
    Nakamura K; Katagai K; Mori K; Higo N; Sato S; Yamamoto K
    Int J Pharm; 2001 May; 218(1-2):93-102. PubMed ID: 11337153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high throughput protein formulation platform: case study of salmon calcitonin.
    Capelle MA; Gurny R; Arvinte T
    Pharm Res; 2009 Jan; 26(1):118-28. PubMed ID: 18600433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation.
    Dogru ST; Calis S; Oner F
    J Clin Pharm Ther; 2000 Dec; 25(6):435-43. PubMed ID: 11123497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs.
    Banga AK; Chien YW
    Pharm Res; 1993 May; 10(5):697-702. PubMed ID: 8321834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
    Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
    Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality analysis of salmon calcitonin in a polymeric bioadhesive pharmaceutical formulation: sample preparation optimization by DOE.
    D'Hondt M; Van Dorpe S; Mehuys E; Deforce D; DeSpiegeleer B
    J Pharm Biomed Anal; 2010 Dec; 53(4):939-45. PubMed ID: 20655159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of salmon calcitonin in spray-dried powder for inhalation. Effect of chitosan.
    Yang M; Velaga S; Yamamoto H; Takeuchi H; Kawashima Y; Hovgaard L; van de Weert M; Frokjaer S
    Int J Pharm; 2007 Mar; 331(2):176-81. PubMed ID: 17126507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.